Alnylam Pharmaceuticals
ALNY
#1073
Rank
A$32.63 B
Marketcap
A$243.63
Share price
5.36%
Change (1 day)
-64.96%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company